Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tumor-induced reshuffling of lipid composition on the endoplasmic reticulum membrane sustains macrophage survival and pro-tumorigenic activity
Giusy Di Conza, Chin-Hsien Tsai, Héctor Gallart‐Ayala, et al.
Nature Immunology (2021) Vol. 22, Iss. 11, pp. 1403-1415
Open Access | Times Cited: 127

Showing 1-25 of 127 citing articles:

The complex role of tumor-infiltrating macrophages
Anthos Christofides, Laura Strauss, Alan T. Yeo, et al.
Nature Immunology (2022) Vol. 23, Iss. 8, pp. 1148-1156
Closed Access | Times Cited: 470
Clinical relevance of tumour-associated macrophages
Mikaël J. Pittet, Olivier Michielin, Denis Migliorini
Nature Reviews Clinical Oncology (2022) Vol. 19, Iss. 6, pp. 402-421
Closed Access | Times Cited: 465
Macrophage diversity in cancer revisited in the era of single-cell omics
Ruoyu Ma, Annabel Black, Bin‐Zhi Qian
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 546-563
Open Access | Times Cited: 360
Metabolic communication in the tumour–immune microenvironment
Kung‐Chi Kao, Stefania Vilbois, Chin‐Hsien Tsai, et al.
Nature Cell Biology (2022) Vol. 24, Iss. 11, pp. 1574-1583
Closed Access | Times Cited: 175
Microenvironment-driven metabolic adaptations guiding CD8+ T cell anti-tumor immunity
Jaeoh Park, Pei‐Chun Hsueh, Zhiyu Li, et al.
Immunity (2023) Vol. 56, Iss. 1, pp. 32-42
Open Access | Times Cited: 155
STAT proteins in cancer: orchestration of metabolism
Yijia Li, Chunyan Zhang, Antons Martincuks, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 3, pp. 115-134
Closed Access | Times Cited: 145
PERK is a critical metabolic hub for immunosuppressive function in macrophages
Lydia Raines, Haoxin Zhao, Yuzhu Wang, et al.
Nature Immunology (2022) Vol. 23, Iss. 3, pp. 431-445
Open Access | Times Cited: 132
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
Matthew D. Park, Ivan Reyes-Torres, Jessica LeBérichel, et al.
Nature Immunology (2023) Vol. 24, Iss. 5, pp. 792-801
Closed Access | Times Cited: 114
Nanomaterials in tumor immunotherapy: new strategies and challenges
Xudong Zhu, Shenglong Li
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 110
STAT3 pathway in cancers: Past, present, and future
Hanqi Wang, Qi‐Wen Man, Fang‐Yi Huo, et al.
MedComm (2022) Vol. 3, Iss. 2
Open Access | Times Cited: 107
Cell death, therapeutics, and the immune response in cancer
Kay Hänggi, Brian Ruffell
Trends in cancer (2023) Vol. 9, Iss. 5, pp. 381-396
Open Access | Times Cited: 106
CD40 signal rewires fatty acid and glutamine metabolism for stimulating macrophage anti-tumorigenic functions
Pu-Ste Liu, Yi-Ting Chen, Xiaoyun Li, et al.
Nature Immunology (2023) Vol. 24, Iss. 3, pp. 452-462
Open Access | Times Cited: 104
The Evolution of Single-Cell RNA Sequencing Technology and Application: Progress and Perspectives
Shuo Wang, Si-Tong Sun, Xinyue Zhang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2943-2943
Open Access | Times Cited: 70
The role of lipid metabolic reprogramming in tumor microenvironment
Kai Yang, Xiaokun Wang, Chenghu Song, et al.
Theranostics (2023) Vol. 13, Iss. 6, pp. 1774-1808
Open Access | Times Cited: 67
Control of tumor-associated macrophage responses by nutrient acquisition and metabolism
Xian Zhang, Liangliang Ji, Ming O. Li
Immunity (2023) Vol. 56, Iss. 1, pp. 14-31
Open Access | Times Cited: 66
Glucose-driven histone lactylation promotes the immunosuppressive activity of monocyte-derived macrophages in glioblastoma
Alessandra De Leo, Alessio Ugolini, Xiaoqing Yu, et al.
Immunity (2024) Vol. 57, Iss. 5, pp. 1105-1123.e8
Closed Access | Times Cited: 59
Control of immune cell function by the unfolded protein response
Giusy Di Conza, Ping‐Chih Ho, Juan R. Cubillos‐Ruiz, et al.
Nature reviews. Immunology (2023) Vol. 23, Iss. 9, pp. 546-562
Closed Access | Times Cited: 51
Cold and hot tumors: from molecular mechanisms to targeted therapy
Bo Wu, Bo Zhang, Bowen Li, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 44
Metabolic regulation of tumor-associated macrophage heterogeneity: insights into the tumor microenvironment and immunotherapeutic opportunities
Yujing Qian, Yujia Yin, Xiaocui Zheng, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 21
Involvement of tumor immune microenvironment metabolic reprogramming in colorectal cancer progression, immune escape, and response to immunotherapy
Andrea Nicolini, Paola Ferrari
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18
The Role of Macrophages in Various Types of Tumors and the Possibility of Their Use as Targets for Antitumor Therapy
Enar Jumaniyazova, А. V. Lokhonina, D. Sh. Dzhalilova, et al.
Cancers (2025) Vol. 17, Iss. 3, pp. 342-342
Open Access | Times Cited: 2
Noninvasive in vivo imaging of macrophages: understanding tumor microenvironments and delivery of therapeutics
Prakash Gangadaran, Akanksha Onkar, Ramya Lakshmi Rajendran, et al.
Biomarker Research (2025) Vol. 13, Iss. 1
Open Access | Times Cited: 2
Unraveling UPR-Mediated Intercellular Crosstalk: Implications for Immunotherapy Resistance Mechanisms
Lu Si, Qimin Zhou, Rongjie Zhao, et al.
Cancer Letters (2025), pp. 217613-217613
Closed Access | Times Cited: 2
Decoding endoplasmic reticulum stress signals in cancer cells and antitumor immunity
Camilla Salvagno, Jay K. Mandula, Paulo C. Rodrı́guez, et al.
Trends in cancer (2022) Vol. 8, Iss. 11, pp. 930-943
Open Access | Times Cited: 60
Chronic type I interferon signaling promotes lipid-peroxidation-driven terminal CD8+ T cell exhaustion and curtails anti-PD-1 efficacy
Weixin Chen, Jia Ming Nickolas Teo, Siu Wah Yau, et al.
Cell Reports (2022) Vol. 41, Iss. 7, pp. 111647-111647
Open Access | Times Cited: 53
Page 1 - Next Page

Scroll to top